Improving patient engagement in genomic research for colorectal cancer.
Genome Characterization Unit
['FUNDING_OTHER'] · UNIVERSITY OF SOUTHERN CALIFORNIA · NIH-10930850
This study is all about finding better ways to involve Hispanic patients with colorectal cancer in genomic research, so they can help improve cancer treatments and support each other during the process.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF SOUTHERN CALIFORNIA (nih funded) |
| Locations | 1 site (Los Angeles, UNITED STATES) |
| Trial ID | NIH-10930850 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing participant engagement in genomic studies, particularly for Hispanic patients diagnosed with colorectal cancer. The University of Southern California's Center for Optimization of Participant Engagement for Cancer Characterization aims to develop best practices for involving patients in genomic research. By leveraging a diverse patient population and experienced genome scientists, the project seeks to improve recruitment and participation in cancer genome sequencing initiatives. The center will coordinate activities and strategies to ensure effective engagement and support for patients throughout the research process.
Who could benefit from this research
Good fit: Ideal candidates for this research are Hispanic patients diagnosed with colorectal cancer.
Not a fit: Patients who do not have colorectal cancer or are not of Hispanic descent may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and treatment options for colorectal cancer in Hispanic populations.
How similar studies have performed: Previous research has shown success in improving patient engagement in genomic studies, particularly within diverse populations.
Where this research is happening
Los Angeles, UNITED STATES
- UNIVERSITY OF SOUTHERN CALIFORNIA — Los Angeles, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CRAIG, DAVID W — UNIVERSITY OF SOUTHERN CALIFORNIA
- Study coordinator: CRAIG, DAVID W
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancer Biology, Cancers